Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|17|1|4-15

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.1, 2017-01, pp. : 4-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Guided Design of Antibodies

By  

Current Computer - Aided Drug Design, Vol. 6, Iss. 2, 2010-06 ,pp. : 128-138

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery

By  

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 501-526

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting enzyme inhibitors in drug discovery

By Copeland Robert A   Harpel Mark R   Tummino Peter J  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 967-978

Informa Healthcare

Access to resources Recommend Favorite

Targeting Cysteine Residues of Biomolecules: New Approaches for the Design of Antiviral and Anticancer Drugs

By  

Current Medicinal Chemistry, Vol. 9, Iss. 12, 2002-06 ,pp. : 1167-1185

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design in drug discovery - the application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands

By Pritchard M.C.   Raphy J.   Singh L.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite